Recent publications published by researchers at the MRC WIMM.
RNA Polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation.
Martell DJ. et al, (2023), medRxiv
Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
Scott C. et al, (2022), Br J Haematol, 198, e10 - e14
The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin.
Truch J. et al, (2022), Nat Commun, 13
Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.
Scott C. et al, (2021), Haematologica, 106, 2960 - 2970
Genetic and functional insights into CDA-I prevalence and pathogenesis.
Olijnik A-A. et al, (2021), J Med Genet, 58, 185 - 195
Modelling erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I)
Scott C. et al, (2019)
A tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactions.
Brown JM. et al, (2018), Nat Commun, 9
Overexpression of a family of RPEL proteins modifies cell shape.
Favot L. et al, (2005), FEBS Lett, 579, 100 - 104
Capsaicin-sensitive afferents are involved in signalling transneuronal effects between cutaneous sensory nerves.
Scott C. et al, (2000), Neuroscience, 95, 535 - 541
Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat.
Walker JS. et al, (2000), Neuropeptides, 34, 193 - 202
Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
Binder W. et al, (1999), Eur J Neurosci, 11, 2065 - 2072
Use of protease inhibitors increases the amounts of substance P extracted from small specimens of nerve tissue.
Scott C. et al, (1996), Anal Biochem, 233, 156 - 159